microRNA-29c and microRNA-223 down-regulation has in vivo significance in chronic lymphocytic leukemia and improves disease risk stratification.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Blood

• Publication date

  2009-05-21

• Fields of study

  Medicine

• Identifiers
  DOI 10.1182/blood-2008-11-189407PMID 19144983
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prognostic markers in chronic lymphocytic leukemia: a comprehensive review.

  2009cited by this paper
• Stathmin 1: a novel therapeutic target for anticancer activity

  2008cited by this paper
• New prognostic markers in chronic lymphocytic leukemia.

  2008cited by this paper
• Regulation of progenitor cell proliferation and granulocyte function by microRNA-223

  2008cited by this paper
• MicroRNA-223 is commonly repressed in hepatocellular carcinoma and potentiates expression of Stathmin1.

  2008cited by this paper
• Mcl-1 expression has in vitro and in vivo significance in chronic lymphocytic leukemia and is associated with other poor prognostic markers.

  2008cited by this paper
• CD49d expression is an independent predictor of overall survival in patients with chronic lymphocytic leukaemia: a prognostic parameter with therapeutic potential

  2008cited by this paper
• MicroRNA 29c is down-regulated in nasopharyngeal carcinomas, up-regulating mRNAs encoding extracellular matrix proteins

  2008cited by this paper
• MicroRNAs and noncoding RNAs in hematological malignancies: molecular, clinical and therapeutic implications

  2008cited by this paper
• Doubling time of soluble CD23: a powerful prognostic factor for newly diagnosed and untreated stage A chronic lymphocytic leukemia patients

  2008cited by this paper
• A study of pre-validation

  2008cited by this paper
• Quantitative technologies establish a novel microRNA profile of chronic lymphocytic leukemia.

  2007cited by this paper
• MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B

  2007cited by this paper
• MicroRNA‐223 is a key factor in osteoclast differentiation

  2007cited by this paper
• Lipoprotein lipase mRNA expression in whole blood is a prognostic marker in B cell chronic lymphocytic leukemia.

  2007cited by this paper
• Quantification of ZAP70 mRNA in B cells by real-time PCR is a powerful prognostic factor in chronic lymphocytic leukemia.

  2007cited by this paper
• Epigenetic silencing of the myelopoiesis regulator microRNA-223 by the AML1/ETO oncoprotein.

  2007cited by this paper
• Tcl1 expression in chronic lymphocytic leukemia is regulated by miR-29 and miR-181.

  2006cited by this paper
• A microRNA expression signature of human solid tumors defines cancer gene targets

  2006cited by this paper
• The predictive value of lipoprotein lipase for survival in chronic lymphocytic leukemia.

  2006cited by this paper
• A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia.

  2005cited by this paper
• Cancer genomics: Small RNAs with big impacts

  2005cited by this paper
• A minicircuitry comprised of microRNA-223 and transcription factors NFI-A and C/EBPalpha regulates human granulopoiesis.

  2005cited by this paper
• miR-15 and miR-16 induce apoptosis by targeting BCL2.

  2005cited by this paper
• The functions of animal microRNAs

  2004cited by this paper
• Intensified Cloning Efforts Have Revealed Numer

  2004cited by this paper
• MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias.

  2004cited by this paper
• ZAP-70 expression and prognosis in chronic lymphocytic leukaemia.

  2004cited by this paper
• MicroRNA-Directed Cleavage of HOXB8 mRNA

  2004cited by this paper
• Conservation of the heterochronic regulator Lin-28, its developmental expression and microRNA complementary sites.

  2003cited by this paper
• Erratum to “Conservation of the heterochronic regulator Lin-28, its developmental expression and microRNA complementary sites”: [Dev. Biol. 258 (2003) 432–442]☆

  2003cited by this paper
• Genomic aberrations and survival in chronic lymphocytic leukemia.

  2000cited by this paper
• Clinico‐prognostic implications of simultaneous increased serum levels of soluble CD23 and β2‐microglobulin in B‐cell chronic lymphocytic leukemia

  1999cited by this paper
• Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia.

  1999cited by this paper
• Chronic lymphocytic leukemic B cells but not normal B cells are rescued from apoptosis by contact with normal bone marrow stromal cells.

  1998cited by this paper
• Lymphocyte doubling time in chronic lymphocytic leukaemia: analysis of its prognostic significance

  1986cited by this paper

• Circulating microRNAs Expression as Prognosis Biomarker of Cholangiocarcinoma.

  2026cites this paper
• Unveiling the role of microRNAs, the PI3K/AKT pathway, and their associations in various types of leukemia: a comprehensive review

  2025cites this paper
• Developing Potent Therapeutics for Liver Cancer Chemoresistance via an RNA Nanotech and Series-Circuit-Christmas-Bulb Mechanism Targeting ABC Transporters.

  2025cites this paper
• Different plasma exosome isolation methods generated distinct microRNA and protein profiles in healthy controls and patients with advanced prostate and lung cancer

  2025cites this paper
• Dysregulated MicroRNAs in Chronic Lymphocytic Leukemia

  2024cites this paper
• MiR-223-3p in Cancer Development and Cancer Drug Resistance: Same Coin, Different Faces

  2024cites this paper
• MicroRNA Profiling as a Predictive Indicator for Time to First Treatment in Chronic Lymphocytic Leukemia: Insights from the O-CLL1 Prospective Study

  2024cites this paper
• MiRNAs in Hematopoiesis and Acute Lymphoblastic Leukemia

  2023cites this paper
• The Significant Role of microRNAs in Gliomas Angiogenesis: A Particular Focus on Molecular Mechanisms and Opportunities for Clinical Application

  2023cites this paper
• miR-223 Plays A Key Role in Obesogen-Enhanced Adipogenesis in Mesenchymal Stem Cells and in Transgenerational Obesity.

  2023cites this paper
• 2-Methoxyestradiol combined with ascorbic acid facilitates the apoptosis of chronic myeloid leukemia cells via the microRNA-223/Fms-like tyrosine kinase 3/phosphatidylinositol-3 kinase/protein kinase B axis

  2022cites this paper
• Evaluation of miRNA 223/125a and COBLL1 Expressions and ROR-1 Levels as Reliable Markers in B- chronic Lymphocytic Leukemia

  2022cites this paper
• miR-223 Plays A Critical Role in Obesogen-Enhanced Adipogenesis in Mesenchymal Stem Cells and in Transgenerational Obesity

  2022cites this paper
• The role of extracellular vesicles and interleukin-8 in regulating and mediating neutrophil-dependent cancer drug resistance

  2022cites this paper
• Relevance of miR-223 as Potential Diagnostic and Prognostic Markers in Cancer

  2022influential citation
• Exosome application in treatment and diagnosis of B-cell disorders: leukemias, multiple sclerosis, and arthritis rheumatoid

  2022cites this paper
• MicroRNA-22 contributes to dexamethasone-induced osteoblast differentiation inhibition and dysfunction through targeting caveolin-3 expression in osteoblastic cells

  2021cites this paper
• MicroRNA: A signature for cancer progression.

  2021cites this paper
• Distribution of microRNA profiles in pre-clinical and clinical forms of murine and human prion disease

  2021cites this paper
• Distribution of microRNA profiles in pre-clinical and clinical forms of murine and human prion disease

  2021cites this paper
• MicroRNAs: New non-invasive diagnostic biomarkers and therapeutic method for cancer treatment

  2021cites this paper
• One Omics Approach Does Not Rule Them All: The Metabolome and the Epigenome Join Forces in Haematological Malignancies

  2021cites this paper
• Evaluation of microRNA-223 and microRNA-125a expression association with STAT3 and Bcl2 genes in blood leukocytes of CLL patients: a case–control study

  2021cites this paper
• The many facets of miR‐223 in cancer: Oncosuppressor, oncogenic driver, therapeutic target, and biomarker of response

  2021cites this paper
• Changes in miR-29 levels and their predictive value of a cure after diamminedichloroplatinum chemotherapy in patients with nasopharyngeal carcinoma

  2020cites this paper
• The Expression of Different Micrornas in Iraqi Patients with Childhood Acute Leukemia and Their Association to C/EBP-Î’ Serum Level

  2020cites this paper
• Progressive Control of Streptococcus agalactiae-Induced Innate Inflammatory Response Is Associated with Time Course Expression of MicroRNA-223 by Neutrophils

  2020cites this paper
• Role of Chronic Lymphocytic Leukemia (CLL)-Derived Exosomes in Tumor Progression and Survival

  2020cites this paper
• Serum levels of hsa-miR-16-5p, -29a-3p, -150-5p, -155-5p and -223-3p and subsequent risk of chronic lymphocytic leukemia in the EPIC study

  2020cites this paper
• Assessing prognosis of chronic lymphocytic leukemia using biomarkers and genetics

  2020cites this paper
• Importance of Crosstalk Between Chronic Lymphocytic Leukemia Cells and the Stromal Microenvironment: Direct Contact, Soluble Factors, and Extracellular Vesicles

  2020cites this paper
• Serum levels of hsa‐miR‐16‐5p, hsa‐miR‐29a‐3p, hsa‐miR‐150‐5p, hsa‐miR‐155‐5p and hsa‐miR‐223‐3p and subsequent risk of chronic lymphocytic leukemia in the EPIC study

  2020cites this paper
• Prognostic models for newly-diagnosed chronic lymphocytic leukaemia in adults: a systematic review and meta-analysis.

  2020cites this paper
• Targeting microRNA in hematologic malignancies.

  2020cites this paper
• miR-29 Modulates CD40 Signaling in Chronic Lymphocytic Leukemia by Targeting TRAF4: an Axis Affected by BCR inhibitors.

  2020cites this paper
• MicroRNAs in Cancer: From Diagnosis to Therapeutics

  2020cites this paper
• The role of non-coding genome in the behavior of infiltrated myeloid-derived suppressor cells in tumor microenvironment; a perspective and state-of-the-art in cancer targeted therapy.

  2020cites this paper
• MicroRNA-223 decreases cell proliferation, migration, invasion, and enhances cell apoptosis in childhood acute lymphoblastic leukemia via targeting Forkhead box O 1

  2020influential citation
• Downregulation of miR-223 expression is an early event during mammary transformation and confers resistance to CDK4/6 inhibitors in luminal breast cancer.

  2019cites this paper
• BMP-2 and miR-29c in osteosarcoma tissues on proliferation and invasion of osteosarcoma cells

  2019cites this paper
• Early Diagnosis of Gestational Diabetes Mellitus Using Circulating MicroRNAs.

  2019cites this paper
• miR-223-5p Suppresses Tumor Growth and Metastasis in Non-Small Cell Lung Cancer by Targeting E2F8

  2019cites this paper
• MicroRNA-2233 p functions as a tumor suppressor by regulating cell cycle in hepatocellular carcinoma

  2019cites this paper
• The importance of helminthic microRNAs in pathology

  2019cites this paper
• EPIGENETIC MECHANISMS OF TUMOR PROGRESSION IN CHRONIC LYMPHOID LEUKEMIA

  2019cites this paper
• Prevention of cancer dormancy by Fbxw7 ablation eradicates disseminated tumor cells.

  2019cites this paper
• Sweroside ameliorated carbon tetrachloride (CCl4)-induced liver fibrosis through FXR-miR-29a signaling pathway

  2019cites this paper
• Association between elevated plasma microRNA-223 content and severity of coronary heart disease

  2018cites this paper
• ASCL2 expression contributes to gastric tumor migration and invasion by downregulating miR223 and inducing EMT

  2018cites this paper
• Study of microRNA Profile as a Molecular Biomarker in Egyptian Chronic Lymphocytic Leukemia

  2018cites this paper
• Chronic Lymphocytic Leukemia

  2018cites this paper
• MicroRNA-223 Suppresses the Canonical NF-κB Pathway in Basal Keratinocytes to Dampen Neutrophilic Inflammation

  2018cites this paper
• Epigenetic deregulation in chronic lymphocytic leukemia: Clinical and biological impact.

  2018cites this paper
• Prognostic Indicators in CLL: Clinical, Cytogenetics, Novel Mutations, MicroRNAs, Hierarchal Classification

  2018cites this paper
• B-Cell Receptors

  2018cites this paper
• miR-223靶向调控SOX11在套细胞淋巴瘤中的预后意义

  2018cites this paper
• DAGNOSIS AND PROGNOSIS OF ACUTE

  2017cites this paper
• MicroRNA-29 family functions as a tumor suppressor by targeting RPS15A and regulating cell cycle in hepatocellular carcinoma.

  2017cites this paper
• Targeted deep sequencing reveals clinically relevant subclonal IgHV rearrangements in chronic lymphocytic leukemia

  2017cites this paper
• Extracellular vesicles of bone marrow stromal cells rescue chronic lymphocytic leukemia B cells from apoptosis, enhance their migration and induce gene expression modifications

  2017cites this paper
• MicroRNAs in CLL: miRacle or miRage for prognosis and targeted therapies?

  2017cites this paper
• The role of miRNA-223 in cancer: Function, diagnosis and therapy.

  2017cites this paper
• miR-223 is repressed and correlates with inferior clinical features in mantle cell lymphoma through targeting SOX11.

  2017cites this paper
• Circulating microRNA expressions can predict the outcome of lenalidomide plus low-dose dexamethasone treatment in patients with refractory/relapsed multiple myeloma

  2017cites this paper
• Untersuchung der direkten Regulation der miR-29c- und miR-146a-abhängig exprimierten Zielgene mittels Reportergensassay im ALK-positiven ALCL

  2017cites this paper
• Nuevas aportaciones de la hibridación in situ fluorescente y el estado mutacional del gen de las cadenas pesadas de inmunoglobulinas para predecir el curso clínico de los pacientes con leucemia linfocítica crónica

  2017cites this paper
• Prognostic markers and DNA methylation profiling in lymphoid malignancies

  2017cites this paper
• Lipoprotein Lipase Expression in Chronic Lymphocytic Leukemia: New Insights into Leukemic Progression

  2017cites this paper
• Regulatory function of membrane trafficking components in exosome secretion and cancer progression

  2017cites this paper
• The effect of circulating miR-223 on surveillance of different cancers: a meta-analysis

  2017cites this paper
• Genetic alterations in Adult T cell leukemia

  2017cites this paper
• MicroRNAs in chronic lymphocytic leukemia: miRacle or miRage for prognosis and targeted therapies?

  2016cites this paper
• Characterization of microRNAs expression during zebrafish skeletal development

  2016cites this paper
• hsa-miR-29c and hsa-miR-135b differential expression as potential biomarker of gastric carcinogenesis.

  2016cites this paper
• MiR-223-3p as a Novel MicroRNA Regulator of Expression of Voltage-Gated K+ Channel Kv4.2 in Acute Myocardial Infarction

  2016cites this paper
• Role of miR-223/paired box 6 signaling in temozolomide chemoresistance in glioblastoma multiforme cells

  2016cites this paper
• miR-582-5P induces colorectal cancer cell proliferation by targeting adenomatous polyposis coli

  2016cites this paper
• miR-223 increases gallbladder cancer cell sensitivity to docetaxel by downregulating STMN1

  2016cites this paper
• Targeting Brutons Tyrosine Kinase in Chronic Lymphocytic Leukemia at the Crossroad between Intrinsic and Extrinsic Pro-survival Signals

  2016cites this paper
• The role of MicroRNAs in human cancer

  2016cites this paper
• The SCF-type E3 Ubiquitin Ligases as Cancer Targets.

  2016cites this paper
• Clinical significance of microRNAs in chronic and acute human leukemia

  2016cites this paper
• MiRNA expression profile of chronic lymphocytic leukemia patients with 13q deletion.

  2016cites this paper
• MicroRNA-223 Regulates the Differentiation and Function of Intestinal Dendritic Cells and Macrophages by Targeting C/EBPβ.

  2015cites this paper
• Loss of miR-223 and JNK Signaling Contribute to Elevated Stathmin in Malignant Pleural Mesothelioma

  2015cites this paper
• microRNA and Chronic Lymphocytic Leukemia.

  2015cites this paper
• MicroRNAs as Potential Biomarkers in Cancer: Opportunities and Challenges

  2015cites this paper
• Sex differences and estrogen regulation of miRNAs in lupus, a prototypical autoimmune disease.

  2015cites this paper
• Circulating microRNAs as novel prognosis biomarkers for head and neck squamous cell carcinoma

  2015cites this paper
• [Construction and identification of recombinant lentivirus vector for microRNA-223 overexpression and suppression].

  2015cites this paper
• Circulating microRNA-223 as a potential biomarker for obesity.

  2015cites this paper
• A suppressive role of ionizing radiation-responsive miR-29c in the development of liver carcinoma via targeting WIP1

  2015cites this paper
• De Novo Acute Myeloid Leukemia in Adults: Suppression of MicroRNA-223 is Independent of LMO2 Protein Expression BUT Associate With Adverse Cytogenetic Profile and Undifferentiated Blast Morphology

  2015cites this paper
• MiR-204 regulates HMGA2 expression and inhibits cell proliferation in human thyroid cancer

  2015cites this paper
• miRNAs : EMERGING PLAYERS IN HEMATOLOGICAL DISORDERS

  2015cites this paper
• MicroRNA-223 is a novel negative regulator of HSP90B1 in CLL

  2015cites this paper
• c-Myc-miR-29c-REV3L signalling pathway drives the acquisition of temozolomide resistance in glioblastoma.

  2015cites this paper
• Lipoprotein Lipase SNPs rs13702 and rs301 Correlate with Clinical Outcome in Chronic Lymphocytic Leukemia Patients

  2015cites this paper
• Molecular basis of chronic lymphocytic leukemia diagnosis and prognosis

  2015cites this paper
• The Emerging Role of miRNAs in HTLV-1 Infection and ATLL Pathogenesis

  2015cites this paper